IRIS
CICCIA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.069
AS - Asia 6.768
NA - Nord America 4.928
SA - Sud America 1.492
Continente sconosciuto - Info sul continente non disponibili 582
AF - Africa 111
OC - Oceania 4
Totale 25.954
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.965
US - Stati Uniti d'America 4.761
SG - Singapore 2.335
IE - Irlanda 1.306
CN - Cina 1.249
BR - Brasile 1.211
VN - Vietnam 1.173
HK - Hong Kong 1.092
IT - Italia 480
GB - Regno Unito 422
KR - Corea 347
DE - Germania 290
GR - Grecia 174
IN - India 170
AR - Argentina 111
FR - Francia 78
CA - Canada 70
JP - Giappone 63
FI - Finlandia 61
BD - Bangladesh 54
ID - Indonesia 52
EC - Ecuador 50
MX - Messico 47
SE - Svezia 46
UA - Ucraina 38
TR - Turchia 37
ZA - Sudafrica 34
NL - Olanda 32
CO - Colombia 31
AT - Austria 30
PL - Polonia 30
ES - Italia 28
IQ - Iraq 25
PK - Pakistan 24
PY - Paraguay 21
VE - Venezuela 20
MA - Marocco 19
UZ - Uzbekistan 19
BE - Belgio 18
JM - Giamaica 17
PE - Perù 17
CH - Svizzera 16
EG - Egitto 15
TH - Thailandia 15
CL - Cile 12
CZ - Repubblica Ceca 12
KE - Kenya 12
DZ - Algeria 11
AE - Emirati Arabi Uniti 10
KZ - Kazakistan 10
SA - Arabia Saudita 10
TW - Taiwan 9
UY - Uruguay 9
AZ - Azerbaigian 8
BO - Bolivia 8
PH - Filippine 8
JO - Giordania 7
MY - Malesia 7
NP - Nepal 7
RS - Serbia 7
GT - Guatemala 6
IL - Israele 5
OM - Oman 5
PA - Panama 5
TN - Tunisia 5
AL - Albania 4
CR - Costa Rica 4
HN - Honduras 4
MK - Macedonia 4
PT - Portogallo 4
AU - Australia 3
CI - Costa d'Avorio 3
GA - Gabon 3
GE - Georgia 3
HU - Ungheria 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MD - Moldavia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IR - Iran 2
LB - Libano 2
LT - Lituania 2
NG - Nigeria 2
NO - Norvegia 2
RO - Romania 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
Totale 25.356
Salva come PNG Salva come JPEG
Città #
Moscow 3.132
Dublin 1.305
Santa Clara 1.066
Hong Kong 1.055
Singapore 956
San Jose 464
Jacksonville 401
Ho Chi Minh City 394
Seoul 343
Ashburn 318
Hanoi 282
Hefei 257
Beijing 202
Princeton 187
Roxbury 187
Chandler 176
Medford 140
Bremen 121
Naples 95
Bengaluru 90
São Paulo 89
Los Angeles 85
New York 83
Da Nang 76
Dallas 64
Des Moines 63
Ann Arbor 51
Cambridge 50
Boardman 49
Munich 46
The Dalles 44
Council Bluffs 43
Haiphong 41
Wilmington 41
Rome 40
Jinan 37
Rio de Janeiro 35
Nanjing 30
Atlanta 28
Falkenstein 25
Nuremberg 25
Belo Horizonte 24
Biên Hòa 24
Curitiba 24
Frankfurt am Main 23
Guarulhos 23
Turku 23
Tokyo 22
Boston 21
Chennai 21
Hải Dương 21
Dearborn 20
Guayaquil 20
Orem 20
Phoenix 20
Brasília 19
Porto Alegre 19
Guangzhou 18
Montreal 18
Shanghai 18
Bắc Ninh 17
London 17
Ninh Bình 17
Tashkent 17
Amsterdam 16
Campinas 16
Hebei 16
Helsinki 16
Johannesburg 16
Lappeenranta 16
Milan 16
Warsaw 16
Buenos Aires 15
Houston 15
Shenyang 15
Brussels 14
Caserta 14
Mexico City 14
Vũng Tàu 14
Bangkok 13
Hillsboro 13
Jakarta 13
Phủ Lý 13
Salvador 13
San Francisco 13
Vienna 13
Can Tho 12
Goiânia 12
Palermo 12
Thái Bình 12
Bến Tre 11
Norwalk 11
Ribeirão Preto 11
Thái Nguyên 11
Tianjin 11
Brooklyn 10
Huế 10
Lima 10
Memphis 10
Quito 10
Totale 13.155
Salva come PNG Salva come JPEG
Nome #
Ankylosing spondylitis: an autoimmune or autoinflammatory disease? 199
An intense physical rehabilitation programme determines pain relief and improves the global quality of life in patients with fibromyalgia 173
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 168
pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease 165
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 152
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 150
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 146
CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis 139
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 138
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 135
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 135
Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery 132
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 132
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab 131
CD8+tissue-resident memory T cells are expanded in primary Sjögren’s disease and can be therapeutically targeted by CD103 blockade 129
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 129
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 129
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 128
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort 128
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 126
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 126
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 125
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome 124
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease 124
Precision medicine in systemic lupus erythematosus 122
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 121
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 120
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 119
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 118
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 118
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 118
IL-23 OVEREXPRESSION AS IMMUNOLOGICAL SIGNATURE OF SUBCLINICAL INTESTINAL INFLAMMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS 118
Adult-onset Still's disease with elderly onset: results from a multicentre study 118
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 117
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 117
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 116
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 116
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 116
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 114
Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease 113
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity 113
ILC3 in Axial Spondyloarthritis: the Gut Angle 113
Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity 112
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 111
New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine? 111
Gut dysbiosis in Spondyloarthritis: Cause or effect? 111
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 110
Subclinical gut inflammation in ankylosing spondylitis 110
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region 109
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-Associated spondyloarthritis 109
Autophagy occurs in lymphocytes infiltrating Sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions 109
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 108
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort 107
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity 107
NKP44+NK cells are expanded and produce high amounts of IL-22 in the salivary glands of Sjrogen syndrome patients 107
Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients 107
JAK/STAT Pathway Targeting in Primary Sjögren Syndrome 107
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 106
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 105
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 104
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 104
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 103
The gut-enthesis axis and the pathogenesis of Spondyloarthritis 103
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 103
Real-life efficacy of guselkumab in patients with early psoriatic arthritis 103
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database 102
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 102
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 102
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 101
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 101
The craniovertebral junction in rheumatoid arthritis: State of the art 101
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 100
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis 100
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis 100
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 100
Short-Facelift Approach in Temporal Artery Biopsy: Is It Safe? 99
null 99
Intestinal Involvement in Kawasaki Disease 99
IVIG in APS pregnancy 99
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 99
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 98
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 98
The Cross-Talk between Microbiome and Metabolome in Rheumatoid Arthritis 98
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 98
Gut inflammation in spondyloarthritis 98
Inflammasome activation in Ankylosing Spondylitis is associated to gut dysbiosis 98
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 98
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry 97
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 97
Interstitial lung disease in systemic sclerosis: current and future treatment 97
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis 97
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 97
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 96
Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion 96
Autophagy in the pathogenesis of ankylosing spondylitis 96
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study 96
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 95
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 95
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 95
Cardiovascular disease in primary sjögren’s syndrome 95
Totale 11.375
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.625
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022989 0 11 1 24 372 4 37 16 48 28 66 382
2022/20231.724 246 12 26 17 208 59 4 60 1.020 5 43 24
2023/20241.032 35 30 39 55 368 101 27 29 11 7 57 273
2024/20254.236 14 45 9 88 646 518 478 439 537 940 304 218
2025/202616.031 545 866 894 963 1.266 8.304 1.231 582 674 309 212 185
2026/2027562 182 380 0 0 0 0 0 0 0 0 0 0
Totale 25.954